Overview of This Study:
This study involved four major activities in estimating the current size of the chiral chromatography column market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market.
The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were used to estimate the total market size. After that, the market breakdown and data triangulation were done to determine the market size of the segments and sub-segments.
Expected Growth in Revenue:
The chiral chromatography column market size is projected to reach 123 million USD by 2025 from an estimated 99 million USD in 2020, at a CAGR of 4.5% during the forecast period. Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well ast he emergence of green chemistry,is likely to provide opportunities for the chiral chromatography column industry.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435
The pharmaceutical & biotechnology companies end-user segment is expected to grow at the highest CAGR from 2020 to 2025.
Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period.
Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.
The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.
The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA. Therefore, the high demand of metal-based columns in the pharmaceutical industry is expected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.
The prepacked column is expected to grow at the highest CAGR during the forecast period.
Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on a daily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.
Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.
Key Players:
To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography column market. The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex (US).
Growth Strategies Adopted by Them:
These players are adopting various strategies to increase their share in the chiral chromatography column market. Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography column industry.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435
